Genetics of Breast and Gynecologic Cancers (PDQ®)–Health Professional Version
SECTIONS
- Executive Summary
- Introduction
- Penetrance of Inherited Susceptibility to Hereditary Breast and/or Gynecologic Cancers
- Multigene (Panel) Testing
- High-Penetrance Breast and/or Gynecologic Cancer Susceptibility Genes
- Moderate-Penetrance Genes Associated With Breast and/or Gynecologic Cancer
- Low-Penetrance Genes and Loci
- Clinical Management of Carriers of BRCAPathogenic Variants
- Clinical Management of Other Hereditary Breast and/or Gynecologic Cancer Syndromes
- Psychosocial Issues in Inherited Breast and Ovarian Cancer Syndromes
- Changes to This Summary (01/16/18)
- About This PDQ Summary
- View All Sections
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Updated statistics with estimated new breast, ovarian, and endometrial cancer cases and deaths for 2018 (cited American Cancer Society as reference 1).
This summary is written and maintained by the PDQ Cancer Genetics Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
.png)
No hay comentarios:
Publicar un comentario